FDA Warning Letter — Guangdong Renhe Guozhuang Biotechnology Co., Ltd.
The FDA took a Warning Letter action against Guangdong Renhe Guozhuang Biotechnology Co., Ltd. on December 16, 2025 (Guangzhou, China). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- Guangdong Renhe Guozhuang Biotechnology Co., Ltd.
- Date
- December 16, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Guangzhou (China)